|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn951416094 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160606s2016 nyu o 001 0 eng |
| 010 |
|
|
|a 2016026293
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d EBLCP
|d YDX
|d IDB
|d SNK
|d DKU
|d AUW
|d BTN
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d DLC
|d OCLCO
|d OCLCQ
|
| 019 |
|
|
|a 959032283
|a 962437819
|
| 020 |
|
|
|a 9781634853408
|q (ebook)
|
| 020 |
|
|
|a 1634853407
|
| 020 |
|
|
|z 9781634853293
|q (softcover)
|
| 020 |
|
|
|z 1634853296
|
| 029 |
1 |
|
|a AU@
|b 000062422212
|
| 035 |
|
|
|a (OCoLC)951416094
|z (OCoLC)959032283
|z (OCoLC)962437819
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a QP562.A7
|
| 060 |
|
4 |
|a QU 60
|
| 072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 612.3/98
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a L-arginine :
|b structure, dietary sources and beneficial effects /
|c Benjamin L. Soto, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publisher's, Inc.,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Biochemistry research trends
|
| 500 |
|
|
|a Includes index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a L-ARGININE: STRUCTURE, DIETARY SOURCES AND BENEFICIAL EFFECTS; L-ARGININE: STRUCTURE, DIETARY SOURCES AND BENEFICIAL EFFECTS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: IS ARGININE TRULY A "MIRACLE MOLECULE"?: A CRITICAL EVALUATION OF NUTRITIONAL ARGININE SUPPLEMENTATION FROM A BIOCHEMICAL POINT OF VIEW; ABSTRACT; ABBREVIATIONS; INTRODUCTION; Arginine, the Multifaceted Amino Acid; 2. ARGININE AVAILABILITY UNDER NORMAL CONDITIONS; 2.1. Arginine Absorption and Transport; 2.2. De novo Arginine Synthesis; 3. ARGININE PATHWAYS IN MAMMALIAN CELLS.
|
| 505 |
8 |
|
|a 3.1. Nitric Oxide Synthesis3.2. The Arginase Pathway; 3.3. Synthesis of Creatine from Arginine; 3.4. Homoarginine Synthesis from L-arginine; 3.5. Arginine Decarboxylation Yields Agmatine; 3.6. Arginine Metabolism and Post-Translational Modifications; 3.6.1. Methylated Arginine Synthesis; Protein Arginine Methylation Reactions; 3.6.2. Peptidyl Citrulline Formation by Protein Arginine Deiminase; 4. ARGININE SUPPLEMENTATION IN VARIOUS DISEASES; 4.1. Arginine Supplementation and the Cardiovascular System; 4.2. Homoarginine and Cardiovascular Disorders.
|
| 505 |
8 |
|
|a 4.3. Arginine Supplementation and the Respiratory System4.4. Arginine Supplementation and Inflammation; 4.5. Arginine Supplementation and Cancer; 4.6. Arginine Supplementation and the Endocrine System; 4.6.1. Diabetes Mellitus; 4.6.2. Arginine and Growth Hormone; 4.7. Arginine in Pregnancy; 4.8. Arginine Utilization in Dentistry; 5. ARGININE SUPPLEMENTATION IN HEALTHY PERSONS; 5.1. Arginine Supplementation in Professional Physical Training; 5.2. Arginine Supplementation in Non-Professional Physical Training; 5.3. Arginine Supplementation in Healthy Persons as "Prevention."
|
| 505 |
8 |
|
|a 5.4. A Short Summary on the Possible Risks of Arginine SupplementationCONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: L-ARGININE AND NITRIC OXIDE HOMEOSTASIS; ABSTRACT; 1. INTRODUCTION; 2. L-ARGININE -- SUBSTRATE FOR NITRICOXIDE BIOSYNTHESIS; 2.1. L-arginine and Nitric Oxide Synthase; 2.2. L-arginine and Arginase; 2.3. NO-Synthase vs Arginase; 2.4. L-arginine Utilization by Other Enzymes; 3. L-ARGININE AND NITRIC OXIDE INPHYSIOLOGICAL CONDITION; 4. L-ARGININE AND NITRIC OXIDE IN PATHOLOGICAL CONDITION; 5. BIOAVAILABILITY OF L-ARGININE; 6. THERAPEUTIC USE OF L-ARGININE; CONCLUSION.
|
| 505 |
8 |
|
|a ACKNOWLEDGMENTSREFERENCES; Chapter 3: L-ARGININE AND CARDIOMETABOLIC HEALTH: BRIEF OVERVIEW; ABSTRACT; INTRODUCTION; ARGININE AND CARDIOMETABOLIC HEALTH: MOLECULAR PATHWAYS; SAFETY AND POSSIBLE (DRUG-NUTRIENT) INTERACTIONS OF SUPPLEMENTAL ARGININE; CONCLUSION; REFERENCES; PROFESSIONAL APPOINTMENTS; EDUCATION; PUBLICATIONS (LAST 3 YEARS); Scientific papers; Book chapters; Chapter 4: NOVEL SYNTHETIC BIODEGRADABLE ARGININE-RICH IMPLANTABLE BIOMATERIALS AND DEVICES FOR HUMAN BODY REPAIR AND RECONSTRUCTION; ABSTRACT; 1. INTRODUCTION.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Arginine
|x Physiological effect.
|
| 650 |
|
0 |
|a Arginine
|x Metabolism.
|
| 650 |
|
2 |
|a Arginine
|x physiology
|
| 650 |
|
2 |
|a Arginine
|x metabolism
|
| 650 |
|
6 |
|a Arginine
|x Effets physiologiques.
|
| 650 |
|
6 |
|a Arginine
|x Métabolisme.
|
| 650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
| 700 |
1 |
|
|a Soto, Benjamin L.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t L-arginine
|d Hauppauge, N.Y. : Nova Science Publisher's, Inc., [2016]
|z 9781634853293
|w (DLC) 2016019035
|
| 830 |
|
0 |
|a Biochemistry research trends series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1345687
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12973994
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1345687
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4691153
|
| 994 |
|
|
|a 92
|b IZTAP
|
